Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide

被引：11
|
作者：
Saviola, A [1 ]
Luppi, M [1 ]
Potenza, L [1 ]
Morselli, M [1 ]
Ferrari, A [1 ]
Riva, G [1 ]
Torelli, G [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Sect Haematol, Dept Haematol & Oncol, I-4100 Modena, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 123卷 / 04期
关键词：
veno-occlusive disease; leukaemia; gemtuzumab ozogamicin; defibrotide; Mylotarg;
D O I：
10.1046/j.1365-2141.2003.04667.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [31] SOS for veno-occlusive disease: defibrotide prophylaxis
    Platzbecker, Uwe
    Bornhaeuser, Martin
    LANCET, 2012, 379 (9823): : 1277 - 1278
  • [32] Hepatic Veno-Occlusive Disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case
    Cecinati, Valerio
    Giordano, Paola
    De Leonardis, Francesco
    Grassi, Massimo
    Arcamone, Giampaolo
    De Mattia, Domenico
    Santoro, Nicola
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2009, 31 (04) : 702 - 705
  • [33] Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation
    P Chevallier
    T Prebet
    P Turlure
    M Hunault
    S Vigouroux
    J-L Harousseau
    D Blaise
    N Ifrah
    N Milpied
    M Mohty
    Bone Marrow Transplantation, 2010, 45 : 165 - 170
  • [34] Prevention and treatment of hepatic veno-occlusive disease
    Carreras, Enric
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (09): : 635 - 640
  • [35] Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation
    Chevallier, P.
    Prebet, T.
    Turlure, P.
    Hunault, M.
    Vigouroux, S.
    Harousseau, J-L
    Blaise, D.
    Ifrah, N.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 (01) : 165 - 170
  • [36] Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
    Chopra, R
    Eaton, JD
    Grassi, A
    Potter, M
    Shaw, B
    Salat, C
    Neumeister, P
    Finazzi, G
    Iacobelli, M
    Bowyer, K
    Prentice, HG
    Barbui, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) : 1122 - 1129
  • [37] Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Corbacioglu, Selim
    Kernan, Nancy
    Lehmann, Leslie
    Brochstein, Joel
    Revta, Carolyn
    Grupp, Stephan
    Martin, Paul
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 291 - 302
  • [38] Hepatic veno-occlusive disease
    Aversa, F.
    PEDIATRIC REPORTS, 2012, 4 : 87 - 89
  • [39] Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease
    Triplett, Brandon M.
    Kuttab, Hani I.
    Kang, Guolian
    Leung, Wing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2148 - 2153
  • [40] Gemtuzumab ozogamicinFirst report of hepatic veno-occlusive disease: 2 case reports
    Reactions Weekly, 2001, 878 (1) : 9 - 10
12345